{
  "experiment_id": "aa7227018343fa2a5f6df22ada9bd727",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "9082f66c620d0bc6fea9232b665ebcbe",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": true,
  "timestamp": "2025-11-13T04:06:48.222968",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\" (removed the specific subtype qualifier to use the standard broader term)\n\n2. **assay**: Broadened \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\" (removed the clinical context qualifier to use the standard term)\n\n3. **tumorType**: Broadened \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\" (removed the parenthetical qualifier and standardized capitalization to match the controlled terminology)",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3081,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 623
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01J1pdugywxEnXtq6KBq4CPx",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and match each field to the controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\"\n   - This is a specific subtype of Neurofibromatosis type 1\n   - Looking at the enum values, the broader term would be \"Neurofibromatosis type 1\"\n\n2. **assay**: \"clinical whole-exome sequencing\"\n   - This is a specific type of whole exome sequencing performed in a clinical context\n   - Looking at the enum values, I can see \"whole exome sequencing\" which is the broader, more standard term\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\"\n   - This includes additional qualifiers \"(morphologic abnormality)\" that should be removed\n   - Looking at the enum values, I can see \"Plexiform Neurofibroma\" (with capital N in Neurofibroma)\n   - The exact value in the schema is \"Plexiform Neurofibroma\"\n\nLet me double-check the exact capitalization and spelling from the schema:\n- diagnosis enum includes: \"Neurofibromatosis type 1\" (capital N, lowercase t)\n- assay enum includes: \"whole exome sequencing\" (all lowercase)\n- tumorType enum includes: \"Plexiform Neurofibroma\" (capital P, capital N)\n\nSo the corrected metadata should be:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 microdeletion syndrome\" \u2192 \"Neurofibromatosis type 1\" (removed the specific subtype qualifier to use the standard broader term)\n\n2. **assay**: Broadened \"clinical whole-exome sequencing\" \u2192 \"whole exome sequencing\" (removed the clinical context qualifier to use the standard term)\n\n3. **tumorType**: Broadened \"Plexiform neurofibroma (morphologic abnormality)\" \u2192 \"Plexiform Neurofibroma\" (removed the parenthetical qualifier and standardized capitalization to match the controlled terminology)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3081,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 623
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3081,
          "output_tokens": 623,
          "total_tokens": 3704
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\" (the primary diagnosis, removing the specific tumor type detail)\n\n2. **assay**: Broadened \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\" (removed vendor-specific platform name and standardized to the general assay type)\n\n3. **tumorType**: Broadened \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (malignant triton tumor is a rare histological variant of MPNST with rhabdomyoblastic differentiation; broadened to the standard parent category)",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3076,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 605
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01EhKTuzZx1S7UMybdz7PbAM",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze each field and broaden the narrow synonyms to match the controlled terminology:\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\"\n   - This is a specific description that includes both the main diagnosis and a tumor type\n   - The broader, standard term from the enum should be: \"Neurofibromatosis type 1\"\n   - \"optic pathway glioma\" is actually a tumor type, not part of the diagnosis\n\n2. **assay**: \"Illumina whole exome sequencing \"\n   - This is a specific platform/vendor name with the assay type\n   - The broader, standard term from the enum should be: \"whole exome sequencing\"\n   - We should remove the vendor name \"Illumina\" and any trailing spaces\n\n3. **tumorType**: \"malignant triton tumor\"\n   - A malignant triton tumor is a rare variant of MPNST (Malignant Peripheral Nerve Sheath Tumor) that shows rhabdomyoblastic differentiation\n   - The broader, standard term from the enum should be: \"Malignant Peripheral Nerve Sheath Tumor\"\n\nLet me verify these choices against the enum values:\n- \"Neurofibromatosis type 1\" \u2713 (exact match in diagnosis enum)\n- \"whole exome sequencing\" \u2713 (exact match in assay enum)\n- \"Malignant Peripheral Nerve Sheath Tumor\" \u2713 (exact match in tumorType enum)",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\" (the primary diagnosis, removing the specific tumor type detail)\n\n2. **assay**: Broadened \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\" (removed vendor-specific platform name and standardized to the general assay type)\n\n3. **tumorType**: Broadened \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" (malignant triton tumor is a rare histological variant of MPNST with rhabdomyoblastic differentiation; broadened to the standard parent category)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3076,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 605
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3076,
          "output_tokens": 605,
          "total_tokens": 3681
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a variant of NF1, broadened to the standard diagnostic term\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed platform-specific identifier (MGI) to use the general, technology-agnostic term\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed specific subtype qualifier to use the broader, standard tumor classification",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3075,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 663
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01WBK7k4iNLcKo9pPvG6rC44",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze each field in the input data and map it to the appropriate controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"Watson Syndrome\"\n   - Watson Syndrome is a variant or subtype of Neurofibromatosis type 1 (NF1)\n   - Looking at the enum values for diagnosis, I see \"Neurofibromatosis type 1\" which would be the broader, more standard term\n   - Watson Syndrome should be broadened to \"Neurofibromatosis type 1\"\n\n2. **assay**: \"MGI whole genome sequencing\"\n   - This is a specific sequencing platform (MGI/BGI sequencer) performing whole genome sequencing\n   - Looking at the enum values for assay, I see \"whole genome sequencing\" which is the broader, platform-agnostic term\n   - \"MGI whole genome sequencing\" should be broadened to \"whole genome sequencing\"\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\"\n   - This is a more specific subtype of MPNST\n   - Looking at the enum values for tumorType, I see \"Malignant Peripheral Nerve Sheath Tumor\" which is the broader, standard term\n   - \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" should be broadened to \"Malignant Peripheral Nerve Sheath Tumor\"\n\nLet me verify these mappings against the controlled vocabulary:\n- \"Neurofibromatosis type 1\" - YES, present in diagnosis enum\n- \"whole genome sequencing\" - YES, present in assay enum\n- \"Malignant Peripheral Nerve Sheath Tumor\" - YES, present in tumorType enum\n\nAll mappings are correct and use exact values from the schema.",
                "signature": "EpwNCkgICRABGAIqQCsZEeO9tCKt65GAs9S0FAXBJv4BpOtUZmZf1xQQ663qVavaaVyM6wGUI98IEzFYNxuZ5gOcwe0oVNyYCPJhMkUSDLH1ICV8AXC+lu8hlRoMMcSvDBxErGBZkwmeIjDHDk9m3FlPxHI4hhHnxU9foXFMnK4tCWPSgb4WuwXsyErvEXOKSnbcnMkOpVk9GbsqgQzGpZtqbpHgMt96MIs3NP4rSQuJxv1Pn1e/MVnyPK2G4mRIiAhFmDhbRahbMXBU6I1Zg0Z+6I68coOdZI+1rlXlGvEMpZ1uorSBU5Ils7F8TdFqHzb2vRhuvpdvL2c53nTaZLaRMkDnM/LWhy2LYsRQ/DmP+aqEY/MlS8cM0nomMwj2aXlmK1SdccNDRYcpA1yQHUiUCPwbp5hbKo/oK8ElMDEAxjzlG50etuZVPOF1ykcpKoXicXwKiOP5UrT6uk3nJG7Onot7OtyzBpzGpJs5hO70CxmIayHbKDgdNIMCCQDvfrlrn/i3kEg6g3PbZeDoQdngZXxTIKZHoAu/tUyH5LSc360ocRLj/OQ1VCiTbRA4M/JGCK4YIa82wE6UEvxsZmsPPEH5YggntcwKyra5OgBehX083IlnciKwrUsUWlHz9mdZBIEH86ky0G2m4zoboI49zgptct5X+cFcPvsJ2328XaBOyYsiwcUmggrDsxhi/UBJbMFdNN4mP3u2mba5FE+SrFp16zl3tUXDioCFHSYXQzW6yLHm6NvaCkkRHauN5TDwsKSvi/OKXNms9N6X65DJRiMxVSmkWsDZd6ZWAMhRiSzsEX51MKrp5G6YLV3Y//MZPfa47SRGDszHK/NYP7dGnRR9VQHG2B4gGfKzFVk91lCCL/CiuICBCddmpoLdIaX6O1nYjnEZAaTnj1P9UkfDaP6NSB1mBZ9s2HqAnp6HVSMW+7VVNPeYcWUwi06v4/8CKIN09bih5WIQ/afbEupM/PBpVheHU2pKnmeopOOdGODBsV3HVo8Kgd1/HUpYbfGIHsjiGGUj+snYvfSQF5V5LGD5Epk7rxhejADSvoiKe6Oi8vN4TEkxSc+GuWIwVZW8mJIiLcQ2ZZ3UYdK2+VFcQtlbM+i5NQ53A3rbfhXIofLLRA9DNSg1HLx0Lwz5+c0GpDGnCq1BXkevbs3QIBXpp6tk0ZipOcIVNAkOAHnLw3f9WxKbCZzgC13iQpgcB6ba7Y/ZO95tMbvjsNChFABEq1O0MgZkNO9Etdh4IwEEilWUhyTl+ulMdhaJfK8ga+leimLImYXJ3mduTfPOvo6e610zI90A/t9NU+H7ImR9UkbhQhbdyZmSp9Av6vmKIQEzJZ5dhbTvqYoVVdeIKe5Oak9CeClS+qnEiU6/6yUyl9QDAs6078R8EljX6lPCtPJ5O7h4Zu17aQQfEAsb8ALzGro6oVLNy+vuiq0isJ51uI5c+6/VZSaMhWn3g2Snr7o31TprkrJe3X5++/SRTfoYHu5Fuz2ayOdTKyjInEglGez8GfGEL/Mq97EKTTMwV8vFmmbTSkHY1lBCtiq1V4zbcq8nJDRCqJvlnPknYa9PdMGvjynYvLGXCs5SJEuWZwKwCx6cgE3pUPOty+XDT3BC2j3ebD6OAaTcu5TFoB+D7DPpQPqwhYuctbdYC9Y9VAuXw2gxNHorCjmNtV9x+2zQX2uU0btM/ZXEAyUyxex9ob8SU8Uyp5pH9UrcYm9WA6boM5hT/zpwo/bhE2InfgAjRRFqz/c8j+p19x7T2fJEV0kWvRkDDSA2BDmocEl3w+GK7WiwOIVh1wGD3Q1oboXn1C3rbwGhFizYWBlWithHO62KZf7CgeeBuzUmiZxbgABaBApS40iLyIOGrwSyUUUXvrcGumXe0NJi4OrJbnL+2zhl6uhUbSsYx4Dxt4HpclhoApG/Bvo7kEQ4HU6LHAacoP5/lgnIlwPuwO2m3o59lOlkvBQh6q2yhxPMmwXWuDR2/CWnDdegOjzNYPhaUF+ThDFg00XIXRDn+OkOop9VSOUdZ3JASop5tV/kZWcFue/5ASh3j2zGCUqtGJgo5K2KBj/oYlQ1bQJK3gfH6esRxydw/x8PQkFs+rclXwv3lQ2qemT4q+fluMvS6pOmZUYrufdr/mYyFnPd+1cqedrNCpKZFmTuz91MWdnkSYyGgVy39cM1ReeWpTf4kRhS60LUHeurJKhhW8v/rPfkAqzd/L6oH4scTX8jNibTCTbKhEFZaeYDuyUR5HstDl+0GAE="
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a variant of NF1, broadened to the standard diagnostic term\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed platform-specific identifier (MGI) to use the general, technology-agnostic term\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed specific subtype qualifier to use the broader, standard tumor classification"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3075,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 663
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3075,
          "output_tokens": 663,
          "total_tokens": 3738
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"NF2-related schwannomatosis\"\n   - Familial spinal neurofibromatosis is a narrow, historical term typically associated with the NF2 spectrum, broadened to the standard controlled term.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" refers to the machine configuration rather than the imaging technique itself. Broadened to the standard general MRI term.\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term for unknown tumor type.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3063,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 1411
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01JhzkWjo2xYV2ihuSMrAqyH",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and match it to the controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\"\n   - This is a specific/narrow term for a type of neurofibromatosis\n   - Looking at the enum values, I need to find the broader, standard term\n   - The available options include:\n     - \"Neurofibromatosis type 1\"\n     - \"NF2-related schwannomatosis\"\n     - \"Schwannomatosis\" (various types)\n     - \"Unknown\"\n   - \"Familial spinal\" neurofibromatosis is typically referring to NF2 or schwannomatosis variants\n   - However, without more specific information, and given that this is clearly a neurofibromatosis condition, the most appropriate broader term might be:\n     - If it's spinal, it could be NF2-related or schwannomatosis-related\n     - \"NF2-related schwannomatosis\" is in the list\n     - But actually, familial spinal neurofibromatosis is often associated with NF2\n   - Looking more carefully, \"familial spinal\" is a variant description, but the broader diagnosis category would likely be \"NF2-related schwannomatosis\" or possibly just \"Neurofibromatosis type 1\"\n   - Actually, familial spinal neurofibromatosis can refer to NF2, but given the broadening task, \"NF2-related schwannomatosis\" seems most appropriate\n   - Wait, let me reconsider. Neurofibromatosis familial spinal could be:\n     - A variant of NF1, or\n     - Related to NF2, or\n     - A form of schwannomatosis\n   - Given it says \"neurofibromatosis\" explicitly, the safest broader term might be \"Neurofibromatosis type 1\" unless there's evidence it's NF2\n   - However, spinal involvement is more characteristic of NF2 or schwannomatosis\n   - I think the most appropriate broader term here is \"NF2-related schwannomatosis\" given the spinal qualifier. The spinal presentation points toward NF2, which typically manifests with spinal tumors. I'll map this to \"NF2-related schwannomatosis\" as the broader controlled term.\n\n2. **assay**: \"\n\nopen MRI\" describes the machine configuration rather than the imaging technique itself. The underlying method is still standard MRI, so I'll use \"conventional MRI\" as the most appropriate general term.\n\n3. **tumorType**: The value explicitly states the tumor type is unknown, so I'll map this to \"Unknown\".\n\nNow I need to reconsider the diagnosis. \"Neurofibromatosis, familial spinal\" could refer to either NF1 or NF2. NF1 is the most common form of neurofibromatosis, making it a safer choice when the specific type isn't clearly indicated. I should use \"Neurofibromatosis type 1\" instead.\n\nActually, I'm second-guessing myself. Familial spinal neurofibromatosis is an older term that predates modern genetic classification. It's now recognized as part of the NF2 spectrum, so \"NF2-related schwannomatosis\" fits better. Since there's no general \"Neurofibromatosis\" option available and familial spinal forms typically fall under NF2, I'll stick with \"NF2-related schwannomatosis\" as the broader term.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"NF2-related schwannomatosis\"\n   - Familial spinal neurofibromatosis is a narrow, historical term typically associated with the NF2 spectrum, broadened to the standard controlled term.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" refers to the machine configuration rather than the imaging technique itself. Broadened to the standard general MRI term.\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term for unknown tumor type."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3063,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 1411
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3063,
          "output_tokens": 1411,
          "total_tokens": 4474
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" \u2192 \"immunohistochemistry\" \n   - Removed the tissue-specific qualifier \"of skin\" to match the standard controlled terminology\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the histological pattern descriptor \"storiform\" to use the broader, standard term from the controlled vocabulary\n\n3. **diagnosis**: No change needed - \"Not Applicable\" already matches the controlled terminology exactly",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3063,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 483
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01B4ahSYHFfCz64z24RDqcHA",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and match it to the controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"Not Applicable\"\n   - This exactly matches \"Not Applicable\" in the enum, so no change needed.\n\n2. **assay**: \"immunohistochemistry of skin\"\n   - This is a narrow/specific term. Looking at the enum values, I can see:\n     - \"immunohistochemistry\" - this is the broader, standard term\n   - The phrase \"of skin\" is making it too specific. The standard term should just be \"immunohistochemistry\"\n\n3. **tumorType**: \"Cutaneous storiform neurofibroma\"\n   - This is a specific subtype of neurofibroma. Looking at the enum values:\n     - \"Cutaneous Neurofibroma\" - this matches and is the broader term for neurofibromas in the skin\n     - The word \"storiform\" is a histological pattern descriptor that makes it more specific\n   - The broader term should be \"Cutaneous Neurofibroma\"\n\nSo the corrected metadata should be:\n- diagnosis: \"Not Applicable\" (no change)\n- assay: \"immunohistochemistry\" \n- tumorType: \"Cutaneous Neurofibroma\"",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" \u2192 \"immunohistochemistry\" \n   - Removed the tissue-specific qualifier \"of skin\" to match the standard controlled terminology\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the histological pattern descriptor \"storiform\" to use the broader, standard term from the controlled vocabulary\n\n3. **diagnosis**: No change needed - \"Not Applicable\" already matches the controlled terminology exactly"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3063,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 483
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3063,
          "output_tokens": 483,
          "total_tokens": 3546
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" (the condition caused by this deletion)\n- **assay**: Broadened \"cell viability assay using Annexin V staining\" to \"cell viability assay\" (the general assay category, removing the specific staining method)\n- **tumorType**: Broadened \"Pedunculated Cutaneous Neurofibroma\" to \"Cutaneous Neurofibroma\" (removing the specific morphological descriptor \"pedunculated\")",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3085,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 565
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_017V5go4VF22G4zY9Pefvugh",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze each field in the input data and match it to the controlled terminology from the Target Schema:\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\"\n   - This is a very specific description of Neurofibromatosis type 1 (NF1). The 17q11.2 deletion is the genetic cause of NF1.\n   - Looking at the enum values, the most appropriate broader term would be \"Neurofibromatosis type 1\"\n\n2. **assay**: \"cell viability assay using Annexin V staining\"\n   - This is a specific type of cell viability assay. \n   - Looking at the enum values, I can see \"cell viability assay\" which is the broader, standard term\n   - The specific method (Annexin V staining) should be generalized to just \"cell viability assay\"\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\"\n   - This is a specific subtype of cutaneous neurofibroma\n   - Looking at the enum values, I can see \"Cutaneous Neurofibroma\" which is the broader term\n   - \"Pedunculated\" describes the shape/attachment but the broader category is \"Cutaneous Neurofibroma\"\n\nSo my output should be:\n- diagnosis: \"Neurofibromatosis type 1\"\n- assay: \"cell viability assay\"\n- tumorType: \"Cutaneous Neurofibroma\"",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" (the condition caused by this deletion)\n- **assay**: Broadened \"cell viability assay using Annexin V staining\" to \"cell viability assay\" (the general assay category, removing the specific staining method)\n- **tumorType**: Broadened \"Pedunculated Cutaneous Neurofibroma\" to \"Cutaneous Neurofibroma\" (removing the specific morphological descriptor \"pedunculated\")"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3085,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 565
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3085,
          "output_tokens": 565,
          "total_tokens": 3650
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"Neurofibromatosis type 1 with scoliosis\" to \"Neurofibromatosis type 1\" (removed the specific comorbidity descriptor)\n- **assay**: Broadened \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" (removed the specific technical variant descriptor)\n- **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (removed the specific morphological descriptor \"sessile\")",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3076,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 461
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Cbc8Q8ic5KftKsMHw4nzeD",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and broaden the narrow synonyms to match the controlled terminology in the Target Schema.\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with scoliosis\"\n   - This is a narrow, specific description that includes a comorbidity (scoliosis)\n   - The broader term in the schema is: \"Neurofibromatosis type 1\"\n   - This is an exact match in the enum list\n\n2. **assay**: \"anti-tag immunocytochemistry\"\n   - This is a specific type of immunocytochemistry using anti-tag antibodies\n   - The broader term in the schema is: \"immunocytochemistry\"\n   - This is an exact match in the enum list\n\n3. **tumorType**: \"sessile cutaneous neurofibroma\"\n   - \"Sessile\" is a specific morphological descriptor meaning the tumor has a broad base of attachment\n   - The broader term in the schema is: \"Cutaneous Neurofibroma\"\n   - This is an exact match in the enum list\n\nI need to ensure I use the exact values from the schema enums, not variations.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"Neurofibromatosis type 1 with scoliosis\" to \"Neurofibromatosis type 1\" (removed the specific comorbidity descriptor)\n- **assay**: Broadened \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" (removed the specific technical variant descriptor)\n- **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (removed the specific morphological descriptor \"sessile\")"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3076,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 461
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3076,
          "output_tokens": 461,
          "total_tokens": 3537
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n- **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\" (peripheral neurofibromatosis is the clinical name for NF1)\n- **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\" (wide bore refers to scanner design, not the imaging technique; conventional MRI is the standard broad term)\n- **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\" (standardized term for cases where tumor type cannot be determined)",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3060,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 633
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01FbNc6zWUF9mssuV2LTjK5d",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and map the narrow synonyms to their broader, standard terms from the Target Schema:\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\"\n   - This refers to Neurofibromatosis type 1 (NF1), which is also known as peripheral neurofibromatosis\n   - From the enum, the exact value should be: \"Neurofibromatosis type 1\"\n\n2. **assay**: \"wide bore MRI\"\n   - This is a type of MRI scan. Wide bore just refers to the physical size of the scanner bore\n   - Looking at the MRI options in the enum:\n     - \"conventional MRI\"\n     - \"Magnetization-Prepared Rapid Gradient Echo MRI\"\n     - \"diffusion MRI\"\n     - \"functional MRI\"\n     - \"magnetic resonance angiography\"\n     - \"magnetic resonance spectroscopy\"\n     - \"resting state functional MRI\"\n     - \"structural MRI\"\n   - Since \"wide bore\" just describes the scanner type and not the specific MRI technique, the most appropriate general/broad term would be \"conventional MRI\" or \"structural MRI\"\n   - \"conventional MRI\" seems like the most appropriate broad term for a general MRI scan\n\n3. **tumorType**: \"no clear diagnosis\"\n   - This indicates that the tumor type is not determined or not applicable\n   - From the enum, the most appropriate values would be:\n     - \"Unknown\" (when the tumor type is not known)\n     - \"Not Applicable\" (when there is no tumor)\n   - Since it says \"no clear diagnosis\", \"Unknown\" seems more appropriate than \"Not Applicable\"\n\nLet me verify my choices:\n- \"Neurofibromatosis type 1\" \u2713 (exact match in enum)\n- \"conventional MRI\" \u2713 (exact match in enum)\n- \"Unknown\" \u2713 (exact match in enum)",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n- **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\" (peripheral neurofibromatosis is the clinical name for NF1)\n- **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\" (wide bore refers to scanner design, not the imaging technique; conventional MRI is the standard broad term)\n- **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\" (standardized term for cases where tumor type cannot be determined)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3060,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 633
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3060,
          "output_tokens": 633,
          "total_tokens": 3693
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"NF2-related schwannomatosis\"\n   - Acoustic neurofibromatosis is an older term for Neurofibromatosis type 2 (NF2), which is now standardly referred to as NF2-related schwannomatosis in modern nomenclature.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The specific library preparation method (ribosomal RNA depletion) is a technical detail that should be broadened to the general assay type \"RNA-seq\".\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - \"Acoustic neuroma\" is an older, narrow term for vestibular schwannoma. The broader standard term is \"Schwannoma\", which encompasses all schwannomas including those on the vestibular nerve.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3073,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 789
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01L5ryKxpNuibZHv3CoaJZ2a",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "I need to broaden narrow synonyms to more general, standard terms using the exact controlled terminology values from the Target Schema.\n\nLet me analyze each field:\n\n1. **diagnosis**: \"acoustic neurofibromatosis\"\n   - \"Acoustic neurofibromatosis\" is an older term for Neurofibromatosis type 2 (NF2), which is characterized by bilateral acoustic neuromas/vestibular schwannomas\n   - Looking at the enum values, I see \"NF2-related schwannomatosis\" and \"Vestibular Schwannoma\"\n   - NF2 is also known as bilateral acoustic neurofibromatosis or central neurofibromatosis\n   - The most appropriate broader term would be \"NF2-related schwannomatosis\" since acoustic neurofibromatosis is the old name for NF2\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\"\n   - This is a specific variation of RNA sequencing\n   - Looking at the enum, I see \"RNA-seq\" which is the broader, standard term\n   - Should broaden to: \"RNA-seq\"\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\"\n   - \"Acoustic neuroma\" is an older term for vestibular schwannoma\n   - These tumors arise from the vestibular portion of the 8th cranial nerve\n   - Looking at the enum, I see \"Schwannoma\" as a general option\n   - Should broaden to: \"Schwannoma\" (the broader term that encompasses vestibular schwannomas)\n\nLet me double-check these choices:\n- diagnosis: \"acoustic neurofibromatosis\" \u2192 \"NF2-related schwannomatosis\" (NF2 is the modern term for what was called acoustic neurofibromatosis)\n- assay: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\" (the general method)\n\n\n- tumorType: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\" (the general tumor type)\n\nAll three mappings align with the controlled vocabulary values available in the schema.",
                "signature": "EuoOCkgICRABGAIqQAXnHLcZy2KJ0mXXBpr833gKEUDKR5zlGNWTJw5LHdqa9M5gzRzcV2n02fWwBUB4s8wpqTCHrik/qghObz/cebgSDJHRrdOPoVv5Qe4B1hoMEq6feiStSzgVD2drIjBx1nJLIVKnJj6iI7ozNMA3F+v+WSkccZoTVfiqxlBTqzXwK+r8iOfehy3LQpfqMnkqzw1cnzBHOjrBFwVdXjCK1RkjKC25k1YHOVStnWgU0hssIqmVML6tf8Dg0DSF00x7+d3KaKe2Z2EoNMtiIGGm/NsVuL6tZufyKxkiub/msqtIWLoJoe1uI75WYaXNlHnxt22HuGt+UToZm0IO3s0a3tn0iTuQPykYPUNukSVAhvTF7H/mCssRkUf8wN+InK0btboXbD3EjzwoC9D7X8sJ2s5zdVaMuQl7kZ2vjsh8W+0RwsnrG5uEyOnXCvmVKXOvQLr2g2jWwba8DloG+d/PwVjK7tA47WFPE3T/StRgEJYdK8uZro/rVfAJhFBd7zjw9i4WK6RSApIodVyZY8TOO2w/cG4L7IOIuk4wB4U2Bvp3FLvhjOY/FEHvx11dnyn5ISNHGmLH7q8Lfgz+JzAYp4+MGfRgv+2ALoZrekGRdbHcvj2XS1k08bbKoqkS9AwtG/07Ru5BlrXEpUc/IbwjK9aRy/R/VJeqKRO0yeCC6nZ99td5mP1WCY5MXgmUAtnFWnUNW2gxo199jd+Inc+hpmhFGF/hXg3Vww6KPgVjAskNcfjqeegcC5mcpDe/b0yDqwfGo2PvEsOhXhQedGr/xnSoNRUU3StoHc4ArHyYk1aFoSkcGc6kHRxBh10zMT4IWG2Hl4LWOJcQIyYXmB33gvxqwh2RzKI5HU49Qs0+N/+umwC9xHT+aCpQ1dGuseItP+8WABi2/rAC57odK4dnbqFA8b4X+rbJPX2/kMaY98AZZ8fuEERdwMfviEuDE/5ZA5V98MMxlkj0W/F6sFDZn3O4RG75IdmJRynlPvbVvInNInZ65Vi/ytsHYsXOawQnlVOxQx8+97geNibvxBnnHQ7nqtdIRPiShj0/wI2ihFsO2WPWIhHu5bDPsv2pfYQUjT4ze19+cWGKLvP3N0zpYL5Dn6TXRaLOAQQTsp+/ItSZdHUertgehT76ck2VSKFXCCxDOMTsJkaYsjDHoyydUOtHRsSf3bfJTX9KOe0Z3eONtnDt2hwGcl7OC5RqkDm74q0oyZkj4eM0eeZ+QnLiEaxGXxDMkGRs7VGQc4xGfOkqMrnSacBab9iSjKGMLUgCKYGaGygUtQQ+K+CxrUHTaRkjEyUyFYRFKCQkaePtKPsdd/B1awOy+gQybqTCUQn8x2JE3bZEW+WHhATUB8nElTaWRIZz5xUkxwFtJnAKUPjbQM/Mo5sh2PGYuQJkeFWCsjEOSKv7LVMTmdmdT7+MkcelmIahaTUUdT/3Rx+TuD3QHdJpvB1AyuRK62mJqNhjBAefcRzgAStIIBnttsSdXNRC29zlSrRXRj0ERnIajYRWmwYolzML7hY3wFympjhLgo48Dny+iV9NgkJ/qjvsULStNekEf1u+/0XXt9vez/G5WsaIIRUd9zF9XxocBN3c7EhG2RaKSsc7A6MPf4jPmvknH9vvHiQ3tTDL2p5+xDQRyAj7iUbIHCJ8jVQZif86IyeWTj+Qh8v7E6UbN92o+7CysUkOhJwAwcWR2rXIdu+K0UMhd+8Faaj7woFGKoTMP5uT28Y2tTZEVLGQEIep8RkjnRMnox56AbiRzuZP7paxb471Cz1szUL28+lIQiBVu3ua3+VOFe3jJuskSNiz2An1MvgN4JCl3XuokGUYGLdSKIoV/CfDfFNyJvasTJjnvPFU9E4l5REKF/UqvEyOMZD+n2uIVwKCKRHAz/BVDmoBTzc9T+oZMstPGmRvmpmL1ACaj+O9zVrBlwYFwBnTZp0fquplxDxD/DcmLH4uNXDX5d+x/ucKOm/Swem+g5IKuw1lMLjKHpBA10AbBvFUSP+sXVTjj3S6ZRUr63uSj5nGaXv6+VclfUfo3ebGMGzNBYNARxcgpccT7HfIkV9j1zaqJUIDTMyDghLNTSbz2lYSGpmwMBG1JGIT+WqPJdckpH3M4wFj2ugh1VSsIgHXN+MzndnDluQTeHpplMrtQ+XsQHX1G/Xx4ibAVUeTkM1hBd82JjWfFb+cOmPAaCPjDhrc8ZxaK0SkP6kVvJwCons2+piR6vZk+52VTOyhf4LC/ZTwJ/FtdRDEg8oCiZAJndRdVQA+5iiPtZ6B514QjEihrM4pcTjKH9IohTm5Uq5lX0UGhliz+sH7BFDZ70XpbJJVuknmuobsZo1zNqH2WBGL2AA//E9c/7uRQ3TFldIkdU71EIvbxyxrSRK3fyrES7mcpqYQ+CQc3LBGHudZyI1R/DMP6Zv0Yhgt3LA0dIpHC8lStbIpcleYn6Mo5hRJ8lxhNvyjtkttD+WdfCLi2YL9KYKP8iLTqTQd1MN5DFkzM7zwNsZ8J7ekWunNkUesxhwYAQ=="
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"NF2-related schwannomatosis\"\n   - Acoustic neurofibromatosis is an older term for Neurofibromatosis type 2 (NF2), which is now standardly referred to as NF2-related schwannomatosis in modern nomenclature.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The specific library preparation method (ribosomal RNA depletion) is a technical detail that should be broadened to the general assay type \"RNA-seq\".\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - \"Acoustic neuroma\" is an older, narrow term for vestibular schwannoma. The broader standard term is \"Schwannoma\", which encompasses all schwannomas including those on the vestibular nerve."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3073,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 789
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3073,
          "output_tokens": 789,
          "total_tokens": 3862
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard term \"Neurofibromatosis type 1\" (removing the specific genetic details to use the general diagnostic category)\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" (a specific commercial product) to \"3D microtissue viability\" (the general assay category for 3D cell viability measurements)\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" (a specific histological subtype) to \"Malignant Peripheral Nerve Sheath Tumor\" (the general tumor category)",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3106,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 806
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01JBmvojR4YK4wViqdFBBvFf",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "I need to examine the input data and match each field to the controlled terminology in the Target Schema. Let me analyze each field:\n\n1. **diagnosis**: \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"\n   - This is a very specific description of Neurofibromatosis type 1\n   - Looking at the enum values, I can see \"Neurofibromatosis type 1\" is in the list\n   - This should be broadened to: \"Neurofibromatosis type 1\"\n\n2. **assay**: \"CellTiter-Glo\u00ae 3D Cell Viability Assay\"\n   - This is a specific commercial product/assay name\n   - Looking at the enum values, I see \"3D microtissue viability\" which relates to 3D cell viability assays\n   - However, there's also \"cell viability assay\" which is more general\n   - Since this is specifically a 3D viability assay, \"3D microtissue viability\" seems most appropriate\n   - Actually, let me reconsider - the instructions say to broaden narrow synonyms. \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" is a brand-specific narrow term. The broader terms available are:\n     - \"cell viability assay\" - this is the general category\n     - \"3D microtissue viability\" - this is more specific to 3D cultures\n   - Since the original mentions \"3D Cell Viability\", and there's \"3D microtissue viability\" in the enum, this seems like the most appropriate match\n\n3. **tumorType**: \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"\n   - This is a specific subtype of MPNST\n   - Looking at the enum values, I see \"Malignant Peripheral Nerve Sheath Tumor\" which is the broader category\n   - This should be broadened to: \"Malignant Peripheral Nerve Sheath Tumor\"\n\nI've mapped the specific input terms to their broader, standardized equivalents in the controlled terminology. This ensures consistency and allows for more generalized data categorization while maintaining the essential clinical information.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard term \"Neurofibromatosis type 1\" (removing the specific genetic details to use the general diagnostic category)\n\n2. **assay**: Broadened \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" (a specific commercial product) to \"3D microtissue viability\" (the general assay category for 3D cell viability measurements)\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" (a specific histological subtype) to \"Malignant Peripheral Nerve Sheath Tumor\" (the general tumor category)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3106,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 806
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3106,
          "output_tokens": 806,
          "total_tokens": 3912
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9333333333333332,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 118.45433640480042,
    "token_usage": {
      "input_tokens": 30758,
      "output_tokens": 7039,
      "total_tokens": 37797
    }
  }
}